CytomX Therapeutics News, CytomX Therapeutics Quote, CTMX Quote

CytomX Therapeutics (NQ:CTMX) Delayed: 1.60 -0.03 (1.84%)

Prev. Close

$1.63

Open

$1.61

52 Wk High

$24.68

52 Wk Low

$9.10

Day High

$1.64

Day Low

$1.58

P/E

N/A

EPS

$0.00

Volume

286,316

Apr 22, 2024 03:12 AM JPMorgan Upgrades CytomX Therapeutics (CTMX) to Neutral, 'Entering a Catalyst Rich Period'
Apr 8, 2024 08:00 AM CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Directed ADC, in a Phase 1 Study in Patients with Advanced Solid Tumors
Apr 4, 2024 04:34 PM Form DEFA14A CytomX Therapeutics,
Apr 4, 2024 04:32 PM Form DEF 14A CytomX Therapeutics, For: May 15
Apr 3, 2024 08:00 AM CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas
Mar 28, 2024 07:13 PM Form 4 CytomX Therapeutics, For: Mar 26 Filed by: McCarthy Sean A.
Mar 25, 2024 05:16 PM Form PRE 14A CytomX Therapeutics, For: May 15
Mar 22, 2024 04:28 PM Form 4 CytomX Therapeutics, For: Mar 20 Filed by: Su Zhen
Mar 22, 2024 04:23 PM Form 3 CytomX Therapeutics, For: Mar 20 Filed by: Su Zhen
Mar 22, 2024 04:07 PM Form 8-K CytomX Therapeutics, For: Mar 20

Entities mentioned with CTMX